Figure 2. The combined results of Non-OPR and cancer-recurrence risk.
For univariate Cox regression, the summary relative risk was 5.31 (95% CI, 1.69 to 16.70) and test of heterogeneity I2 = 0% (P = 0.37) (A); for multivariate Cox regression, the summary relative risk was 2.96 (95% CI, 1.38 to 6.34) and test of heterogeneity I2 = 0% (P = 0.61) (B). The combined analysis showed that Non-OPR was statistically associated with recurrence.